Auteur A. BO

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Are mass-media campaigns effective in preventing drug use? A Cochrane systematic review and meta-analysis

E. ALLARA ; M. FERRI ; A. BO ; A. GASPARRINI ; F. FAGGIANO | 2015
Dans BMJ Open (Vol.5, n°9, 2015) Article : Périodique

Objective: To determine whether there is evidence that mass-media campaigns can be effective in reducing illicit drug consumption and the intent to consume. Design: Systematic review of randomised and non-randomised studies. Methods: We search[...]

Plus d'info

Ajouter à la sélection

Lien externe

Best practice promotion in Europe: A web-based tool for the dissemination of evidence-based demand reduction interventions

M. FERRI ; A. BO | 2013
Dans Drugs: Education, Prevention and Policy (Vol.20, n°4, August 2013) Article : Périodique

Best practice is the best application of available evidence to current activities in the drugs field. In 2008, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) set off the creation of a web-based tool which bridges together s[...]

Plus d'info

Ajouter à la sélection

Lien externe

Children's voices. Experiences and perceptions of European children on drug and alcohol issues

D. OLSZEWSKI ; G. BURKHART ; A. BO | 2010
Rapport

The purpose of this paper is to give meaning and insight into some of the key drug and alcohol issues that affect children from the perspectives of the children themselves. It is not to estimate the relative magnitude of a specific drug or alcoh[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

High-risk drug use and new psychoactive substances. Results from an EMCDDA trendspotter study

OEDT = EMCDDA ; J. MOUNTENEY ; M. RUIZ ; A. BO ; T. GROSHKOVA ; J. MATIAS ; L. VANDAM ; F. CARDOSO ; R. CHRISTIE ; L. MONTANARI ; I. GIRAUDON ; P. GRIFFITHS | 2017
Rapport

This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Media campaigns for the prevention of illicit drug use in young people [Review]

M. FERRI ; E. ALLARA ; A. BO ; A. GASPARRINI ; F. FAGGIANO | 2013
Dans Cochrane Database of Systematic Reviews (n°6, 2013) Article : Périodique

Background: Substance-specific mass media campaigns which address young people are widely used to prevent illicit drug use. They aim to reduce use and raise awareness of the problem. Objectives: To assess the effectiveness of mass media campaig[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe

A. PIRONA ; A. BO ; D. HEDRICH ; M. FERRI ; N. VAN GELDER ; I. GIRAUDON ; L. MONTANARI ; R. SIMON ; J. MOUNTENEY | 2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique

Background: The availability of new psychoactive substances (NPS) in Europe has rapidly increased over the last decade. Although prevalence levels of NPS use remain low in the general European population, there are serious concerns associated wi[...]

Plus d'info

Ajouter à la sélection

Nouveauté

Nine reasons why ecstasy is not quite what it used to be

J. MOUNTENEY ; P. GRIFFITHS ; A. BO ; A. CUNNINGHAM ; J. MATIAS ; A. PIRONA | 2018
Dans International Journal of Drug Policy (Vol.51, January 2018) Article : Périodique

This paper explores the recent resurgence in use of ecstasy/MDMA in Europe and highlights keys areas of continuity and divergence between the ecstasy market of the 1990s and the current MDMA market. Based on a scoping study involving a targeted [...]

Plus d'info

Ajouter à la sélection

Parent-based interventions on adolescent alcohol use outcomes: A systematic review and meta-analysis

A. BO ; A. H. HAI ; J. JACCARD | 2018
Dans Drug and Alcohol Dependence (Vol.191, October 2018) Article : Périodique

Background: The effects of parent-based interventions on adolescent alcohol use are unclear, including what factors moderate intervention effects. This study examines the effects of parent-based interventions on adolescent alcohol use and whethe[...]

Plus d'info

Ajouter à la sélection

Pregnancy and opioid use: strategies for treatment

OEDT = EMCDDA ; S. MINOZZI ; L. AMATO ; M. DAVOLI ; M. FERRI ; A. BO ; R. SIMON | 2014
Rapport

Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birth. The primary goal when treating opioid depen[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Nouveauté

Quality assurance in drug demand reduction in European countries: an overview

M. FERRI ; S. DIAS ; A. BO ; D. BALLOTTA ; R. SIMON ; G. CARRA | 2018
Dans Drugs: Education, Prevention and Policy (Vol.25, n°2, April 2018) Article : Périodique

Background: The EMCDDA, through its network of National Focal Points, collects information on the quality assurance systems for drugs-related interventions across European countries. European National Drug Strategies include recommendations for [...]

Plus d'info

Ajouter à la sélection

Recent changes in Europe's MDMA/ecstasy market. Results from an EMCDDA trendspotter study

OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. CUNNINGHAM ; I. GIRAUDON ; J. MATIAS ; A. PIRONA ; N. VAN GELDER ; A. RYBARSKA ; L. VANDAM ; P. GRIFFITHS | 2016
Rapport

This report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’[...]

Plus d'info

Ajouter à la sélection

Lien externe

Document numérique

Objectif drogues, n°23 - Juillet 2012 - Réduction de la demande de drogue : preuves scientifiques mondiales pour actions locales

M. FERRI ; A. BO | 2012
Bulletin : Périodique

FRANÇAIS : La mise en place de politiques de réduction de la demande de drogue fondées sur des éléments de preuve scientifique est un objectif essentiel de la politique antidrogue aussi bien au niveau national, qu’à celui de l’Union européenne [...]

Plus d'info

Ajouter à la sélection

Lien externe

Documents numériques

Selective prevention: Addressing vulnerability to problem drug use in Europe

G. BURKHART ; V. A. GYARMATHY ; A. BO | 2011
Dans Drugs: Education, Prevention and Policy (Vol.18, n°6, December 2011) Article : Périodique

Following the 2003 publication of the European Union (EU) Council Recommendations and the 2005-2008 and 2009-2012 EU Drugs Action Plans, increasing attention has been given in EU member states’ drug policies to populations that are vulnerable to[...]

Plus d'info

Ajouter à la sélection

Lien externe

Slow-release oral morphine as maintenance therapy for opioid dependence [Protocol]

M. FERRI ; S. MINOZZI ; L. AMATO ; A. BO ; M. DAVOLI | 2012
Dans Cochrane Database of Systematic Reviews (n°5, 2012) Article : Périodique

This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy of slow-release oral morphine (SROM) as an alternative maintenance pharmacotherapy for the treatment of opioid dependence.

Plus d'info

Ajouter à la sélection

The internet and drug markets

OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. OTEO | 2016
Rapport

FRANÇAIS : Comment fonctionnent les marchés des drogues en ligne ? Quelles technologies utilisent-ils ? Quelles relations entretiennent-ils avec le marché traditionnel des drogues ? Comment peuvent-ils être surveillés et contrôlés ? Depuis u[...]

Plus d'info

Ajouter à la sélection

Lien externe

Documents numériques